Potential relevance of type I interferon-related biomarkers for the management of polygenic autoimmune rheumatic diseases with childhood onset. (2023)
Attributed to:
Harnessing molecular signatures to deliver personalised B-cell targeted therapies in Sjogren's syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10067-023-06645-1
PubMed Identifier: 37246197
Publication URI: http://europepmc.org/abstract/MED/37246197
Type: Journal Article/Review
Volume: 42
Parent Publication: Clinical rheumatology
Issue: 7
ISSN: 0770-3198